Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam vs Valproic Acid in Pediatric Status Epilepticus
NCT07052136Completed
- Sponsor
- RESnTEC (Research and Technology) Ltd
- Start
- Nov 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of levetiracetam in status epilepticus (SE) (2 arms), sponsored by RESnTEC (Research and Technology) Ltd. Primary endpoint: Sustained control of seizure activity at 24 hours. Started Nov 2024; status: completed.
02
Drugs
levetiracetam
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT07052136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07052136.